Mapping large numbers of results may take a few moments.
Search Results
Showing 151 - 200 of 427 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Entegrion Inc. | Activity: Research and Development | Company Description Entegrion offers a novel point of care in vitro diagnostic blood coagulation monitoring system for use in human and veterinary medicine. | Location Durham |
| |
Company ENTEX Technologies Inc. | Activity: Research and Development | Company Description ENTEX Technologies provides advanced biological and filtration wastewater treatment that can be customized for various industries. | Location Chapel Hill |
| |
Company ENVIGEN Pharmaceuticals Inc. | Activity: Research and Development | Company Description ENVIGEN develops classes of small drug-like molecules to treat life-threatening diseases including cancer, HIV/AIDS and neurological disorders. | Location Durham |
| |
Company EnviroFlight LLC | Activity: Research and Development | Company Description EnviroFlight provides dried black soldier fly larvae products as a source of sustainable alternative protein. | Location Apex |
| |
Company Enzerna Biosciences Inc. | Activity: Research and Development | Company Description Enzerna Biosciences is a pre-clinical stage company that is leveraging its proprietary RNA editing technology to develop long-term curative gene therapies for rare genetic disorders such as Huntington's Disease and Myotonic Dystrophy. | Location Morrisville |
| |
Company Epigenos Biosciences Inc. | Activity: Research and Development | Company Description Epigenos Biosciences develops personalized epigenome-based therapeutics that leverage site-specific DNA binding technologies to treat disease at the root of gene mis-regulation. | Location Morrisville |
| |
Company EPL Inc. | Activity: Contract Research and Testing | Company Description EPL provides GLP-compliant toxicologic pathology and related services including necropsy, histology, immunohistochemistry, pathology evaluation, EM, stereology, pathology peer reviews, pathology working groups and scientific advisory groups. | Location Durham |
| |
Company Eppin Pharma Inc. | Activity: Research and Development | Company Description Eppin Pharma is developing a non-hormonal male oral contraceptive. | Location Durham |
| |
Company ER Therapeutics LLC | Activity: Research and Development | Company Description ER Therapeutics is developing and commercializing therapeutics for cancer. | Location Chapel Hill |
| |
Company Essential Pharmaceuticals LLC | Activity: Research and Development | Company Description Essential Pharmaceuticals sells organ preservation solutions. | Location Durham |
| |
Company EternaTear Inc. | Activity: Research and Development | Company Description EternaTear had developed a novel artificial tear formulation that provides long lasting ocular lubrication to offer relief from dry eye. | Location Raleigh |
| |
Company Eton Bioscience Inc. | Activity: Contract Research and Testing | Company Description Eton Biosciences specializes in DNA sequencing, oligo synthesis, and DNA prep, while offering other services such as gene and peptide synthesis, mutagenesis and mammalian cell expression. | Location Research Triangle Park |
| |
Company Eurofins BioPharma Product Testing ENCO Inc. | Activity: Contract Research and Testing | Company Description Eurofins BioPharma Product Testing ENCO provides stability studies and analytical services to industrial, consulting and government customers. | Location Cary |
| |
Company Eurofins Built Environment Testing CEI Lab (Cary) | Activity: Contract Research and Testing | Company Description Eurofins Built Environment Testing CEI Lab provides industrial hygiene laboratory services such as asbestos testing, microbiology analysis and fungal analysis. | Location Cary |
| |
Company Eurofins Craft Technologies Inc. | Activity: Contract Research and Testing | Company Description Eurofins Craft Technologies provides analytical and method development services to measure nutritional components in blood, tissues, dietary supplements, food and animal feed. | Location Wilson |
| |
Company Evecxia Inc. | Activity: Research and Development | Company Description Evecxia is developing drugs which amplify serotonin synthesis to treat neuropsychiatric conditions for which current therapies are inadequate. | Location Research Triangle Park |
| |
Company Excelya (Durham) | Activity: Contract Research and Testing | Company Description Excelya provides a full range of services including clinical operations, data management, statistics and programming, pharmacovigilance, and medical writing to the biotechnology, pharmaceutical and medical device industries. | Location Durham |
| |
Company Extrel Therapeutics Inc. | Activity: Research and Development | Company Description Extrel Therapeutics is developing medical devices to protect patients from post-operative infection, pain and inflammation. | Location Raleigh |
| |
Company EydisBio Inc. | Activity: Research and Development | Company Description Eydis Bio is developing a platform of small molecule therapeutics targeting a variety of diseases driven by aberrant inflammatory/autoimmune processes. | Location Durham |
| |
Company Eyedesis Biosciences LLC | Activity: Research and Development | Company Description Eyedesis Biosciences is developing a small-molecule macrophage inhibitor for the treatment of neovascular age related macular degeneration. | Location Chapel Hill |
| |
Company FafaBiotic LLC | Activity: Research and Development | Company Description Fafabiotic develops bioformulations for topical and ingestible probiotics for human health. Fafabiotic also offers consulting services on various aspects of biological product development, from feasibility and technology evaluation to scale-up and readiness for commercialization. | Location Cary |
| |
Company FastBack Bio LLC | Activity: Research and Development | Company Description FastBack Bio is developing CAR-T therapy for treatment of solid tumors. | Location Raleigh |
| |
Company Fennec Pharmaceuticals Inc. | Activity: Research and Development | Company Description Fennec Pharmaceuticals develops a sodium thiosulfate formula for the prevention of ototoxicity from cisplatin in pediatric patients. | Location Research Triangle Park |
| |
Company Fernel Therapeutics Inc. | Activity: Research and Development | Company Description Fernel Therapeutics develops medical devices and pharmaceuticals for the treatment of benign or non-infectious diseases of the pelvic region. | Location Apex |
| |
Company Fervent Pharmaceuticals LLC | Activity: Research and Development | Company Description Fervent Pharmaceuticals develops a nonhormonal product, FP-101, to treat vasomotor symptoms associated with menopause. | Location Greenville |
| |
Company FHI Clinical Inc. | Activity: Contract Research and Testing | Company Description FHI Clinical provides tailored clinical trials services, from protocol design and site assessments to trial planning, implementation and management. | Location Durham |
| |
Company FLAG Therapeutics Inc. | Activity: Research and Development | Company Description FLAG Therapeutics develops cancer therapeutics using new classes of small molecules which have selective dual activity: antiangiogenesis and chemotherapeutic. | Location Raleigh |
| |
Company Focal Medical Inc. | Activity: Research and Development | Company Description Focal Medical develops novel therapeutic products based on its local drug delivery technology platform. | Location Cary |
| |
Company Foundation Medicine Inc. | Activity: Research and Development | Company Description Foundation Medicine develops and provides clinical assays that provide a comprehensive genomic profile to identify molecular alterations in a patient's cancer and match them with targeted therapies and clinical trials. | Location Morrisville |
| |
Company G1 Therapeutics Inc. | Activity: Research and Development | Company Description G1 Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for those affected by cancer. | Location Research Triangle Park |
| |
Company Galaxy Diagnostics Inc. | Activity: Contract Research and Testing | Company Description Galaxy Diagnostics offers advanced molecular and serology testing for hard-to-detect flea- and tick-borne infections. It serves physicians, veterinarians and clinical researchers. | Location Durham |
| |
Company Gateway Bio Inc. | Activity: Research and Development | Company Description Gateway Bio is developing a rapid onset anticoagulant. | Location Durham |
| |
Company GEL Engineering LLC | Activity: Contract Research and Testing | Company Description GEL offers full service organic, inorganic, wet chemistry, radiochemistry and radiobioassay testing for companies with hemp, environmental cleanup or natural disaster projects. | Location Raleigh |
| |
Company GEM Tox Labs | Activity: Research and Development | Company Description GEM Tox Labs conducts research focused on the role of MicroRNA molecules in cancer. | Location Greenville |
| |
Company Gene Master LLC | Activity: Contract Research and Testing | Company Description Gene Master provides contract biomedical research services such as genotyping and vector construction. Gene Master helps design and perform biological experiments. | Location Cary |
| |
Company Genebiology Inc. | Activity: Research and Development | Company Description GeneBiology identifies, patents and develops new parenteral formulations of approved drugs for unmet medical needs using the 505b2 regulatory pathway. | Location Research Triangle Park |
| |
Company GeneCentric Therapeutics Inc. | Activity: Research and Development | Company Description GeneCentric Therapeutics develops molecular diagnostic assays to enable oncologists and their patients to make informed, individualized treatment decisions. | Location Research Triangle Park |
| |
Company Genencine Therapeutics LLC | Activity: Research and Development | Company Description Genencine Therapeutics develops mRNA vaccines for the prevention and treatment of cancer, viral diseases and autoimmune diseases, as well as mRNA therapeutic drugs for genetic diseases. | Location Durham |
| |
Company General Biosystems Inc. | Activity: Contract Research and Testing | Company Description General Biosystems provides gene synthesis, molecular biology, and protein expression and purification services. | Location Durham |
| |
Company Generys Biopharmaceuticals Corp. | Activity: Research and Development | Company Description Generys BioPharmaceuticals develops drugs, formulations and generics for unmet medical needs. Generys also offers therapeutic pipeline portfolio consulting and management services on a contract basis. | Location Chapel Hill |
| |
Company GeneVentiv Therapeutics Inc. | Activity: Research and Development | Company Description GeneVentiv Therapeutics is a gene therapy company developing treatments for blood diseases and disorders, including treatments for Hemophilia A and B with or without inhibitors and for Hemophilia Arthropathy, a degenerative joint disease. | Location Raleigh |
| |
Company Genoverde Biosciences Inc. | Activity: Research and Development | Company Description Genoverde Biosciences is developing improved varieties of industrial hemp through traditional breeding and genetic engineering technologies for agricultural and biomedical applications. | Location Raleigh |
| |
Company Global Vaccines Inc. | Activity: Research and Development | Company Description Global Vaccines is a not-for-profit company that develops vaccines against developing-country diseases such as HIV/AIDS, polio, dengue fever, malaria and viral diarrhea (rotavirus). | Location Chapel Hill |
| |
Company Glycomine Inc. | Activity: Research and Development | Company Description Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding. | Location Chapel Hill |
| |
Company Gradient Medical Inc. | Activity: Research and Development | Company Description Gradient Medical develops interventional oncology therapies to treat primary and metastatic tumors using minimally invasive nanosecond pulsed electric fields. | Location Cary |
| |
Company GreenLight Biosciences Inc. | Activity: Research and Development | Company Description Greenlight Biosciences has developed a cell-free bioprocessing method for the low-cost production of RNA for use in research in vaccine development, vector control, pandemic preparation, crop management and crop pesticides. | Location Research Triangle Park |
| |
Company Grid Therapeutics LLC | Activity: Research and Development | Company Description Grid Therapeutics is developing cancer therapeutics that utilize a unique platform that develops human-derived antibodies for the treatment of multiple cancer types. | Location Durham |
| |
Company Gusto Global LLC | Activity: Research and Development | Company Description Gusto Global is developing a discovery platform that integrates advanced computational and lab-based discovery tools to develop next-generation microbiome-based therapeutics & diagnostics. | Location Research Triangle Park |
| |
Company Hedros Biotechnology | Activity: Research and Development | Company Description Hedros Biotechnology has developed a software platform to create custom bacteriophage cocktails, with the goal to eradicate acute hepatopancreatic necrosis disease (AHPND) in shrimp. | Location Raleigh |
| |
Company Helix3 Inc. | Activity: Contract Research and Testing | Company Description Helix3 is a GLP contract research laboratory that designs and conducts customized in vitro and in vivo genetic toxicology studies for US and EU regulatory submissions. | Location Morrisville |